Consider temporarily discontinuing tirzepatide based on the clinical situation and severity
Otherwise, stick to the official medications from a licensed pharmacy to protect your health
The Centers for Medicare & Medicaid Services (CMS) issued proposed guidance in February 2026 clarifying that "obesity treatment" under the ACA's preventive services mandate includes pharmacotherapy when prescribed by a licensed provider
Weight loss often accelerates as you reach your optimal, higher therapeutic dose
GLP-1 drugs like semaglutide, tirzepatide, and liraglutide mainly cause GI symptoms, nausea, vomiting, diarrhea, constipation, bloating, and can rarely lead to pancreatitis, gallbladder disease, or kidney issues
Some of the GLP-1 medications available in the market include Dulaglutide (Trulicity), Exenatide extended-release (Bydureon BCise), Exenatide (Byetta), Semaglutide (Ozempic), and Liraglutide (Victoza, Saxenda)